...
...

rdif news

Sputnik V 97.2% effective against Covid-19, says RDIF citing data from Belarus

RDIF announced no severe adverse events associated with the vaccination and no deaths related to the vaccination were observed, according to the data from Belarus.
Published on Sept 15, 2021 03:07 pm IST

RDIF says gap between two Sputnik V doses can be increased to 180 days: Report

A medical worker prepares a dose of Russia's Sputnik V Covid-19 vaccine.
Published on Jul 09, 2021 11:05 pm IST

Russia to trial combined AstraZeneca, Sputnik V vaccine in Ukraine

A medical worker fills a syringe with Sputnik V (Gam-COVID-Vac) vaccine as she prepares to vaccinate a Russian Army service member at a clinic in the city of Rostov-On-Don, Russia.
Updated on Jan 03, 2021 09:02 am IST

India to make 300 million doses of Sputnik V in 2021, says Russian Direct Investment Fund chief

A Russian medical worker prepares a shot of Russia's Sputnik V coronavirus vaccine in Moscow on Thursday, Dec. 10, 2020 (AP Photo/Pavel Golovkin)
Updated on Dec 18, 2020 03:30 pm IST

About 80% Indians surveyed want anti-Covid-19 vaccine shot: RDIF

According to the survey results, 73% of the 12,000 respondents from 11 countries, was willing to be vaccinated against the viral disease, while of those aware of Russia’s Sputnik V vaccine and willing to be vaccinated, the number was even higher – four out of every five respondents.
Updated on Nov 18, 2020 09:06 am IST

Russia receives renewed approval for Covid-19 vaccine trials in India: RDIF

Large-scale trials of the Sputnik V vaccine in India were first announced and then knocked back by Indian regulators.
Updated on Oct 18, 2020 04:09 pm IST

Production hurdles hurt Russia’s Covid-19 vaccine targets

A vial of the 'Gam-COVID-Vac', also known as 'Sputnik V', COVID-19 vaccine, developed by the Gamaleya National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), sits alongside a syringe in a kidney dish, ready for administration during a post-registration phase trial at the City Clinic #46 in Moscow, Russia.
Updated on Oct 15, 2020 12:01 pm IST

Russia’s RDIF to sell 32 million Covid-19 vaccine doses to Mexico firm: Reports

The Russian Direct Investment Fund (RDIF), the state sovereign wealth fund backing the vaccine’s development, signed its first export deal with Kazakhstan in August.
Published on Sept 09, 2020 02:49 pm IST